{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:42:32Z","timestamp":1787218952657,"version":"build-2736575974"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","annalsofvascularsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.avsg.2024.05.034","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T09:49:45Z","timestamp":1720950585000},"page":"355-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Racial and ethnic representation in peripheral artery disease randomized clinical trials"],"prefix":"10.1016","volume":"108","author":[{"given":"Khaled I.","family":"Alnahhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaai","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaria","family":"Gouthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Sorour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3325-2023","authenticated-orcid":false,"given":"Fachreza Aryo","family":"Damara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Baffoe-Bonnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betemariam","family":"Sharew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Kirksey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2024.05.034_bib1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and Polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2024.05.034_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/CIRCOUTCOMES.113.000618","article-title":"Socioeconomic inequality and peripheral artery disease prevalence in US adults","volume":"7","author":"Pande","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.avsg.2024.05.034_bib3","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/CIRCRESAHA.121.318243","article-title":"Racial and ethnic disparities in peripheral artery disease","volume":"128","author":"Hackler","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2024.05.034_bib4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIR.0000000000001153","article-title":"Health disparities in peripheral artery disease: a scientific statement from the American heart association","volume":"148","author":"Allison","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2024.05.034_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/hr.2015.134","article-title":"Current therapies and investigational drugs for peripheral arterial disease","volume":"39","author":"Suzuki","year":"2016","journal-title":"Hypertens Res"},{"key":"10.1016\/j.avsg.2024.05.034_bib7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ahj.2007.01.038","article-title":"Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease","volume":"153","author":"Grossman","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.avsg.2024.05.034_bib8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jdiacomp.2019.04.005","article-title":"The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT)","volume":"33","author":"Ujueta","year":"2019","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.avsg.2024.05.034_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/SLA.0000000000001433","article-title":"Prospective randomized double-blinded trial comparing 2 anti-MRSA agents with supplemental coverage of cefazolin before lower extremity revascularization","volume":"262","author":"Stone","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.avsg.2024.05.034_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1353\/hpu.0.0323","article-title":"More than tuskegee: understanding mistrust about research participation","volume":"21","author":"Scharff","year":"2010","journal-title":"J Health Care Poor Underserved"},{"key":"10.1016\/j.avsg.2024.05.034_bib12","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2105\/AJPH.2005.080762","article-title":"Racial\/ethnic differences in physician distrust in the United States","volume":"97","author":"Armstrong","year":"2007","journal-title":"Am J Public Health"},{"key":"10.1016\/j.avsg.2024.05.034_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.18865\/ed.31.2.263","article-title":"Willingness of latinx and african Americans to participate in nontherapeutic trials: it depends on who runs the research","volume":"31","author":"Thetford","year":"2021","journal-title":"Ethn Dis"},{"key":"10.1016\/j.avsg.2024.05.034_bib14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2105\/AJPH.2006.100131","article-title":"Awareness of the tuskegee syphilis study and the US Presidential apology and their influence on minority participation in biomedical research","volume":"98","author":"Katz","year":"2008","journal-title":"Am J Public Health"},{"key":"10.1016\/j.avsg.2024.05.034_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/2229-3485.120175","article-title":"Transparency in recruiting patients for clinical trials","volume":"4","author":"Joshi","year":"2013","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.avsg.2024.05.034_bib16","first-page":"1121","article-title":"Recruiting older patients with peripheral arterial disease: evaluating challenges and strategies","volume":"9","author":"Brostow","year":"2007","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.avsg.2024.05.034_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0033-3549(04)50253-4","article-title":"Defining cultural competence: a practical framework for addressing racial\/ethnic disparities in health and health care","volume":"118","author":"Betancourt","year":"2003","journal-title":"Public Health Rep"},{"key":"10.1016\/j.avsg.2024.05.034_bib18","first-page":"3","article-title":"Clinical trials, culture and language: more than meets the eye? Asia Pac","volume":"14","author":"Janda","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.avsg.2024.05.034_bib19","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archinte.163.12.1469","article-title":"The prevalence of peripheral arterial disease in a racially diverse population","volume":"163","author":"Collins","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.avsg.2024.05.034_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejvs.2018.04.015","article-title":"Inadequate health literacy in patients with arterial vascular disease","volume":"56","author":"Strijbos","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.avsg.2024.05.034_bib21","first-page":"e138","article-title":"Health literacy in african-American communities: barriers and strategies","volume":"4","author":"Muvuka","year":"2020","journal-title":"Health Lit Res Pract"},{"key":"10.1016\/j.avsg.2024.05.034_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5130\/lns.v24i1.4900","article-title":"Predictors of English Health Literacy among U.S. Hispanic Immigrants: the importance of language, bilingualism and sociolinguistic environment","volume":"24","author":"Jacobson","year":"2016","journal-title":"Lit Numeracy Stud"},{"key":"10.1016\/j.avsg.2024.05.034_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.mayocp.2020.06.058","article-title":"Disparities in research participation by level of health literacy","volume":"96","author":"Kripalani","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.avsg.2024.05.034_bib24","series-title":"Health Literacy in Clinical Research: Practice and Impact: Proceedings of a Workshop","year":"2020"},{"key":"10.1016\/j.avsg.2024.05.034_bib25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1370\/afm.940","article-title":"The contribution of health literacy to disparities in self-rated health status and preventive health behaviors in older adults","volume":"7","author":"Bennett","year":"2009","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.avsg.2024.05.034_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/EDBK_100019","article-title":"Financial toxicity and equitable access to\u00a0clinical trials","volume":"39","author":"Chino","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.avsg.2024.05.034_bib27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002030-199807000-00015","article-title":"Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States","volume":"12","author":"Koblin","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.avsg.2024.05.034_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1553-2712.2008.00066.x","article-title":"Systematic bias introduced by the informed consent process in a diagnostic research study","volume":"15","author":"Mitchell","year":"2008","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.avsg.2024.05.034_bib29","first-page":"C12","article-title":"For the uninsured, drug trials are health care","volume":"A1","author":"Kolata","year":"1999","journal-title":"N Y Times Web"},{"key":"10.1016\/j.avsg.2024.05.034_bib30","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/01.CCM.0000054907.33928.48","article-title":"Enrolling the uninsured in clinical trials: an ethical perspective","volume":"31","author":"Pace","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.avsg.2024.05.034_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamaoncol.2015.3924","article-title":"Patient income level and cancer clinical trial participation","volume":"2","author":"Unger","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.avsg.2024.05.034_bib32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11606-007-0372-4","article-title":"Reducing Language barriers and racial\/ethnic disparities in health care: an\u00a0investment in our future","volume":"22","author":"Saha","year":"2007","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.avsg.2024.05.034_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41241-018-0065-9","article-title":"Language as a barrier to cancer clinical trial accrual: assessing consenting team knowledge and practices for cancer clinical trial consent among low English fluency patients","volume":"38","author":"Staples","year":"2018","journal-title":"Appl Cancer Res"},{"key":"10.1016\/j.avsg.2024.05.034_bib34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1186\/s13063-019-3737-1","article-title":"Identifying important barriers to recruitment of patients in randomised clinical studies using a questionnaire for study personnel","volume":"20","author":"Isaksson","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.avsg.2024.05.034_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5001\/omj.2020.40","article-title":"Implications of language barriers for healthcare: a systematic review","volume":"35","author":"Al Shamsi","year":"2020","journal-title":"Oman Med J"},{"key":"10.1016\/j.avsg.2024.05.034_bib36","article-title":"Barriers for cancer clinical trial enrollment: a qualitative study of the perspectives of healthcare providers","volume":"28","author":"Kumar","year":"2022","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.avsg.2024.05.034_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-444-53501-6.00006-8","article-title":"Religion and medical ethics","volume":"118","author":"Green","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.avsg.2024.05.034_bib38","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s13187-014-0696-9","article-title":"Is religiosity related to attitudes toward clinical trials participation?","volume":"30","author":"Daverio-Zanetti","year":"2015","journal-title":"J Cancer Educ"},{"key":"10.1016\/j.avsg.2024.05.034_bib39","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10943-016-0353-1","article-title":"Reflections on cultural preferences and internal medicine: the case of Jehovah\u2019s witnesses and the changing thresholds for blood transfusions","volume":"56","author":"Sagy","year":"2017","journal-title":"J Relig Health"},{"key":"10.1016\/j.avsg.2024.05.034_bib40","article-title":"Positive and negative well-being of older adults with symptomatic peripheral artery disease: a population-based investigation","volume":"9","author":"Rafnsson","year":"2020","journal-title":"JRSM Cardiovasc Dis"},{"key":"10.1016\/j.avsg.2024.05.034_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/hex.13191","article-title":"Evaluation of patient engagement in medicine development: a multi-stakeholder framework with metrics","volume":"24","author":"Vat","year":"2021","journal-title":"Health Expect"},{"key":"10.1016\/j.avsg.2024.05.034_bib42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/cts.12264","article-title":"Case study: community engagement and clinical trial success: outreach to african American women","volume":"8","author":"Johnson","year":"2015","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.avsg.2024.05.034_bib43","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1177\/0272989X11424401","article-title":"Patient and public involvement in clinical practice guidelines","volume":"31","author":"L\u00e9gar\u00e9","year":"2011","journal-title":"Med Decis Making"},{"key":"10.1016\/j.avsg.2024.05.034_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1200\/JOP.2017.028068","article-title":"Patient-oncologist communication: sharing decisions in cancer care","volume":"14","author":"Tattersall","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.avsg.2024.05.034_bib45","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.12454","article-title":"Patient involvement in health care decision making: a review","volume":"16","author":"Vahdat","year":"2014","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.avsg.2024.05.034_bib46","first-page":"284","article-title":"Engaging patients in decision-making and behavior change to promote prevention","volume":"240","author":"Krist","year":"2017","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.avsg.2024.05.034_bib47","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.cjca.2020.03.037","article-title":"Patient and family engagement in care in the cardiac intensive care unit","volume":"36","author":"Goldfarb","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.avsg.2024.05.034_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120930915","article-title":"A prospective community engagement initiative to improve clinical research participation in patients with peripheral artery disease","volume":"8","author":"Levenberg","year":"2020","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.avsg.2024.05.034_bib49","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11121-014-0513-z","article-title":"Assessing the generalizability of randomized trial results to target populations","volume":"16","author":"Stuart","year":"2015","journal-title":"Prev Sci"},{"key":"10.1016\/j.avsg.2024.05.034_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6030\/1939-067X-3.1.19","article-title":"Fundamentals of clinical trial design","volume":"3","author":"Evans","year":"2010","journal-title":"J Exp Stroke Transl Med"},{"key":"10.1016\/j.avsg.2024.05.034_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1472-6963-7-40","article-title":"Effects of residence and race on burden of travel for care: cross sectional analysis of the 2001 US National Household Travel Survey","volume":"7","author":"Probst","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.avsg.2024.05.034_bib52","first-page":"1709","article-title":"Minority enrollment in Parkinson\u2019s disease clinical trials: meta-analysis and systematic review of studies evaluating treatment of neuropsychiatric symptoms","volume":"10","author":"Di Luca","year":"2020","journal-title":"J Park Dis"},{"key":"10.1016\/j.avsg.2024.05.034_bib53","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2105\/AJPH.2020.305579","article-title":"Transportation barriers to health care in the United States: findings from the national health interview survey, 1997\u20132017","volume":"110","author":"Wolfe","year":"2020","journal-title":"Am J Public Health"},{"key":"10.1016\/j.avsg.2024.05.034_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jvn.2018.03.003","article-title":"Challenges in recruitment of persons with peripheral artery disease for exercise studies","volume":"36","author":"Caldieraro-Bentley","year":"2018","journal-title":"J Vasc Nurs"},{"key":"10.1016\/j.avsg.2024.05.034_bib55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ahj.2021.11.019","article-title":"Delayed medical care due to transportation barriers among adults with atherosclerotic cardiovascular disease","volume":"245","author":"Acquah","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.avsg.2024.05.034_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/15265161.2018.1431323","article-title":"Enhance diversity among researchers to promote participant trust in precision medicine research","volume":"18","author":"Sierra-Mercado","year":"2018","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.avsg.2024.05.034_bib57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1470-2045(08)70128-1","article-title":"Improvement of informed consent and the quality of consent documents","volume":"9","author":"Jefford","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.avsg.2024.05.034_bib58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.31486\/toj.19.0105","article-title":"A modern history of informed consent and the role of key information","volume":"21","author":"Bazzano","year":"2021","journal-title":"Ochsner J"},{"key":"10.1016\/j.avsg.2024.05.034_bib59","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/S0140-6736(03)15025-8","article-title":"Does informed consent to research require comprehension?","volume":"362","author":"Sreenivasan","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.avsg.2024.05.034_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179916","article-title":"Patient-experienced burden of treatment in patients with multimorbidity \u2013 a systematic review of qualitative data","volume":"12","author":"Rosbach","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2024.05.034_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10810730.2015.1058442","article-title":"Effect of health literacy on research follow-up","volume":"20","author":"Leak","year":"2015","journal-title":"J Health Commun"},{"key":"10.1016\/j.avsg.2024.05.034_bib63","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/08989621.2013.848801","article-title":"Overcoming language barriers in the informed consent process: regulatory and compliance issues with the use of the \u201cshort form\u201d","volume":"21","author":"Lad","year":"2014","journal-title":"Account Res"},{"key":"10.1016\/j.avsg.2024.05.034_bib64","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1200\/JOP.2017.025288","article-title":"Representation of minorities and women in oncology clinical trials: review of the past 14 years","volume":"14","author":"Duma","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.avsg.2024.05.034_bib65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13187-017-1261-0","article-title":"Training needs of clinical and research professionals to optimize minority recruitment and retention in cancer clinical trials","volume":"34","author":"Niranjan","year":"2019","journal-title":"J Cancer Educ"},{"key":"10.1016\/j.avsg.2024.05.034_bib66","article-title":"Race\/ethnicity reporting and representation in US clinical trials: a cohort study","volume":"11","author":"Turner","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.avsg.2024.05.034_bib67","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1017\/cts.2020.554","article-title":"Training needs of investigators and research team members to improve inclusivity in clinical and translational research participation","volume":"5","author":"Passmore","year":"2021","journal-title":"J Clin Transl Sci"},{"key":"10.1016\/j.avsg.2024.05.034_bib68","series-title":"Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups","year":"2022"},{"key":"10.1016\/j.avsg.2024.05.034_bib69","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/cts.2021.876","article-title":"There\u2019s not much we can do... researcher-level barriers to the inclusion of underrepresented participants in translational research","volume":"6","author":"Passmore","year":"2022","journal-title":"J Clin Transl Sci"},{"key":"10.1016\/j.avsg.2024.05.034_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0079147","article-title":"Gender-heterogeneous working groups produce higher quality science","volume":"8","author":"Campbell","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.avsg.2024.05.034_bib71","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.14682","article-title":"Assessment of trends in the design, accrual, and completion of trials registered in ClinicalTrials.gov by sponsor type, 2000-2019","volume":"3","author":"Gresham","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.avsg.2024.05.034_bib72","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0741-5214(91)90319-P","article-title":"Randomized clinical trials and the society for vascular surgery","volume":"13","author":"Clagett","year":"1991","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2024.05.034_bib73","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.amjcard.2015.09.034","article-title":"Impact of funding source on clinical trial results including cardiovascular outcome trials","volume":"116","author":"Riaz","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.avsg.2024.05.034_bib74","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/lsm.23546","article-title":"Skin of color representation in cosmetic clinical trials: a literature review","volume":"54","author":"Akintilo","year":"2022","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.avsg.2024.05.034_bib75","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.21.01885","article-title":"Minority enrollment in phase II and III clinical trials in urologic oncology","volume":"40","author":"Owens-Walton","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.avsg.2024.05.034_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9380","article-title":"The causes and effects of socio-demographic exclusions from clinical trials","volume":"9","author":"Bartlett","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.avsg.2024.05.034_bib77","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrd.2017.70","article-title":"How much do clinical trials cost?","volume":"16","author":"Martin","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.avsg.2024.05.034_bib78","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/jama.290.1.113","article-title":"Industry funding of clinical trials: benefit or bias?","volume":"290","author":"Chopra","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.avsg.2024.05.034_bib79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting\u00a0parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624004217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509624004217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T22:14:56Z","timestamp":1728512096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509624004217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":76,"alternative-id":["S0890509624004217"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2024.05.034","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and ethnic representation in peripheral artery disease randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2024.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}